← Back to guidelines
Cardiology180 papers

Cortical dysplasia

Last edited: 4/14/2026

Overview

Cortical dysplasia refers to a spectrum of brain malformations resulting from abnormal development of the cerebral cortex, often presenting with epilepsy, developmental delay, and focal neurological deficits in childhood 2.

Diagnosis

  • Clinical Presentation: Epilepsy, developmental delay, focal neurologic signs 2.
  • Imaging: High-resolution MRI is crucial for diagnosis, delineating specific syndromes 2.
  • Pathology: Gross and microscopic features include abnormal neuronal layering and organization; molecular studies aid in understanding epileptogenic circuitry 12.
  • Genetic Testing: Important for accurate family counseling 2.
  • Management

  • Surgical Approaches: Effective for defining and treating epileptogenic regions in selected cases 2.
  • Antiepileptic Drugs (AEDs): First-line treatment; specific drug classes include valproate, levetiracetam, and others, though dosing specifics are not provided 2.
  • Adjunctive Therapies: May include cognitive and physical therapies to address developmental delays 2.
  • Special Populations

  • Pediatrics: Commonly affected, with variable outcomes ranging from severe mental retardation to near-normal cognitive function 2.
  • Comorbidities: Neurocutaneous disorders, neoplasms, and hippocampal sclerosis can be associated with cortical dysplasia 1.
  • Key Recommendations

  • Utilize high-resolution MRI for accurate diagnosis and delineation of specific syndromes (Evidence: Moderate 2).
  • Consider surgical intervention based on precise identification of epileptogenic zones (Evidence: Moderate 2).
  • Incorporate genetic testing for comprehensive family counseling (Evidence: Moderate 2).
  • Tailor antiepileptic drug therapy based on individual patient response and seizure type (Evidence: Weak 2).
  • Provide multidisciplinary support including cognitive and physical therapies for developmental support (Evidence: Expert opinion 2).
  • References

    1 Prayson RA, Spreafico R, Vinters HV. Pathologic characteristics of the cortical dysplasias. Neurosurgery clinics of North America 2002. link80003-1) 2 Whiting S, Duchowny M. Clinical spectrum of cortical dysplasia in childhood: diagnosis and treatment issues. Journal of child neurology 1999. link 3 Billette de Villemeur T, Chiron C, Robain O. Unlayered polymicrogyria and agenesis of the corpus callosum: a relevant association?. Acta neuropathologica 1992. link 4 Friedman DJ, Isdale JM, Jacobson S, Levin SE. Infantile cortical hyperostosis (Caffey's disease): a case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1977. link

    Original source

    1. [1]
      Pathologic characteristics of the cortical dysplasias.Prayson RA, Spreafico R, Vinters HV Neurosurgery clinics of North America (2002)
    2. [2]
      Clinical spectrum of cortical dysplasia in childhood: diagnosis and treatment issues.Whiting S, Duchowny M Journal of child neurology (1999)
    3. [3]
      Unlayered polymicrogyria and agenesis of the corpus callosum: a relevant association?Billette de Villemeur T, Chiron C, Robain O Acta neuropathologica (1992)
    4. [4]
      Infantile cortical hyperostosis (Caffey's disease): a case report.Friedman DJ, Isdale JM, Jacobson S, Levin SE South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG